Tarbox Family Office’s Core Laboratories CLB Stock Holding History

Tarbox Family Office’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-54	Closed	-$1K	–	1160
2020 Q2	$1K	Buy	+54	New	+$968	﹤0.01%	928

Other funds holding CLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tarbox Family Office's CLB Position: Q3 2020 in Review

Tarbox Family Office sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 54 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in CLB in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

Tarbox Family Office reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
Tarbox Family Office sold 54 Core Laboratories shares in Q3 2020, an estimated $1K.
Tarbox Family Office first reported a position in Core Laboratories in Q2 2020 and held it in 1 quarter.
Tarbox Family Office's Core Laboratories position peaked at $1K in Q2 2020.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Tarbox Family Office's 13F filing for Q3 2020, filed 22 Oct 2020.